NEW YORK (GenomeWeb News) – Metabolomics diagnostics and services company Metabolon has sued Stemina Biomarker Discovery alleging infringement of two patents, a month-and-a-half after Stemina filed a lawsuit asking a federal court to find that it does not infringe on two sets of patents held by Metabolon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.